Lung Cancer Screening: Subsequent Evidences of National Lung Screening Trial
Young Sik Park
Tuberc Respir Dis. 2014;77(2):55-59.   Published online 2014 Aug 29     DOI: https://doi.org/10.4046/trd.2014.77.2.55
Citations to this article as recorded by Crossref logo
Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results
Janneta R. Tcherkassova, Sergei A. Tsurkan, Anna I. Prostyakova, Nikolai V. Suganov, Alexander M. Boroda, Albina I. Khamitova, Alexander P. Roytman
Consilium Medicum.2023; 25(6): 406.     CrossRef
Role of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers
Hye-Rin Kang, Jun Yeun Cho, Sang Hoon Lee, Yeon Joo Lee, Jong Sun Park, Young-Jae Cho, Ho Il Yoon, Kyung Won Lee, Jae Ho Lee, Choon-Taek Lee
Journal of Thoracic Oncology.2019; 14(3): 436.     CrossRef
The use of a smartphone application for fast lung cancer risk assessment†
Zalan Szanto, Istvan Benko, Laszlo Jakab, Gabor Szalai, Andras Vereczkei
European Journal of Cardio-Thoracic Surgery.2017; 51(6): 1171.     CrossRef
Lung cancer screening: utility of molecular applications in conjunction with low-dose computed tomography guidelines
John F Palma, Partha Das, Oliver Liesenfeld
Expert Review of Molecular Diagnostics.2016; 16(4): 435.     CrossRef
Why and how would we implement a lung cancer screening program?
Idris Guessous, Jacques Cornuz
Public Health Reviews.2015;[Epub]     CrossRef